Ethos Financial Group, LLC

SEC CIK: 0001954242
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by Ethos Financial Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overview All 13F holders of RXRX Full Q2 2026 holdings

Shares (Q2 2026): 20,398
Value: $60.6K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of RXRX by Ethos Financial Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	20,398	$60.6K	<0.1%	−3,088−13.1%	Reduced	Holders
Q1 2026	23,486	$72.1K	<0.1%	+10,466+80.4%	Added	Holders
Q4 2025	13,020	$53.3K	<0.1%	+13,020	New	Holders